Related Experiment Video
Updated: Dec 23, 2025

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Functional Amyloids and their Possible Influence on Alzheimer Disease
Angus Lau1,2, Matthew Bourkas1,2, Yang Qing Qin Lu1
1Department of Laboratory Medicine & Pathobiology, University of Toronto, Medical Sciences Building, 6th Floor, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.
Amyloid beta (Aβ) and somatostatin (SST) peptides may interact, influencing aggregation. This interaction could be significant in Alzheimer disease (AD) and other neurodegenerative conditions.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Amyloids are implicated in various human diseases and are increasingly found to have natural roles.
- Shared properties of amyloids and their oligomers suggest potential for molecular interactions and aggregation crosstalk.
- The amyloid beta peptide (Aβ) is a key component of Alzheimer disease plaques, while somatostatin (SST) is stored in amyloid form.
Purpose of the Study:
- To review the literature on the interaction between Aβ and SST.
- To explore the biogenesis and interactions of Aβ and SST.
- To assess the potential for Aβ and SST to interact in the brain and their link to Alzheimer disease pathobiology.
Main Methods:
- Literature review focusing on amyloid aggregation, Aβ biogenesis and interactions, and SST biogenesis and interactions.
- Analysis of potential encounters between Aβ and SST in the brain.
- Synthesis of existing data linking SST to Alzheimer disease.
Main Results:
- Aβ and SST share physicochemical characteristics, suggesting potential for mutual influence on aggregation.
- SST is stored in an amyloid form within dense core granules.
- Evidence suggests a link between SST and the pathobiology of Alzheimer disease.
Conclusions:
- The interaction between Aβ and SST is a plausible area of study with implications for Alzheimer disease.
- Crosstalk between functional and disease-associated amyloids may be a general mechanism in dementia etiology.
- Further research into amyloid interactions could reveal broader significance in neurodegenerative diseases.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer's Disease: Treatment